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CMP-NeuSGc has been shown to be transported into mouse liver Golgi vesicles by a specific carrier the characteristics 
of which were investigated in detail. In the system employed, CMP-NeuSGc enters the Golgi vesicles within 2 mitt; trans- 
port was saturable with high concentrations of the sugar-nucleotide and was dependent on temperature. A kinetic analysis 
gave an apparent K,,, of 1.3 PM and a maximal transport velocity of 335 pmol/mg protein per min. Almost identical 
values were obtained with CMP-NeuSAc, under the same incubation conditions. Furthermore, the uptake of CMP- 
NeuSGc was inhibited by CMP-NeuSAc, a substrate analogue. Conversely, the uptake of CMP-NeuSAc was inhibited 
by CMP-NeuSGc to the same extent, leading to the conclusion that the transport of CMP-Neu5Ac and CMP-NeuSGc 
is mediated by the same carrier molecule. This transport system for CMP-NeuSGc involves both CMP and CMP-NeuSGc 
since intravesicular CMP induced the entry of external CMP-NeuSGc. 
Transport; CMP-sialic acid; Golgi vesicle 
1. INTRODUCTION 
The sialic acids are a family of N- and O- 
substituted derivatives of neuraminic acid (5 
amino-3,5-di-deoxy-D-glycero-P_D-galacto-non- 
ulosonic acid), whose two principal members are 
N-acetylneuraminic acid (NeuSAc) and N- 
glycoloylneuraminic acid (NeuSGc) [ 11. They occur 
most frequently as the terminal sugar residues on 
the glycan chains of many glycoconjugates. During 
the formation of glycoconjugate-bound NeuSAc, 
the activated sugar nucleotide, CMP-NeuSAc, 
which is present in the cytosol, has to gain access to 
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the lumen of the Golgi apparatus where it serves as 
the sialic acid donor for the sialyltransferases. 
Several laboratories have demonstrated the up- 
take of CMP-NeuSAc into mouse liver microsomes 
[2], rat liver Golgi vesicles [3], and plasma- 
membrane-permeabilized mouse thymocytes 141. 
The saturation of this uptake by increasing concen- 
trations of CMP-NeuSAc, its inhibition by sub- 
strate analogues and dependence on temperature 
indicate that a specific carrier system is involved in 
the transport of CMP-NeuSAc into the Golgi 
lumen. The recent finding that the biosynthesis of 
NeuSGc results from the hydroxylation of CMP- 
NeuSAc by a soluble, possibly cytosolic enzyme [5] 
prompts the suggestion that the CMP-NeuSGc 
product might also enter the Golgi lumen by means 
of a similar carrier system. 
In the present paper, we characterize the uptake 
of CMP-[‘4C]Neu5Gc into Golgi vesicles isolated 
from mouse liver. The data provide evidence that 
these membranes contain a high-affinity transport 
system for CMP-NeuSGc. A kinetic analysis and 
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competition experiments are performed to examine 
whether CMP-NeuSGc and CMP-NeuSAc share 
the same carrier mblecule. The effect of luminal 
CMP on the transport process is also studied. 
2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
All reagents were of analytical grade. CMP-[i4C]Neu5Ac 
(9.69 GBq/mmol) was purchased from Amersham Interna- 
tional (Bucks., England). CMP-NeuSAc, CMP, bovine serum 
albumin and fetuin were of the highest purity available and were 
obtained from Sigma (St. Louis, MO). 
2.2. Isolation of Golgi vesicles from mouse liver 
Golgi vesicles, derived from the livers of 4 week-old Swiss 
mice, were isolated using a modification of the subcellular frac- 
tionation procedure originally described by Balch et al. [6]. The 
mice were killed with chloroform, the liver excised and placed in 
ice-cold STM (0.25 M sucrose; 10 mM Tris-HCl, pH 7.4; 1 mM 
MgClr). All subsequent operations were carried out at 4°C. 
After passage through a tissue press, the finely divided liver was 
homogenized with 4 strokes in a 30 ml Potter homogenizer (B. 
Braun, Melsungen) at low speed (750 rpm) into 3 vols of STM 
buffer. The crude homogenate was adjusted to 1.4 M sucrose by 
the addition of ice-cold 10 mM Tris-HCl (pH 7.4) containing 
2.3 M sucrose and 1 mM EDTA. 3 ml of the latter buffer was 
loaded into a Beckman SW 27 tube and overlaid with 3 ml of 
10 mM Tris-HCl (pH 7.4) containing 1.6 M sucrose, and then 
with 10 ml of the 1.4 M sucrose-containing crude homogenate. 
This was subsequently overlaid with 10 ml of 10 mM Tris-HCl 
(pH 7.4) containing 1.2 M sucrose and fmally with 10 ml of 
0.8 M sucrose in 10 mM Tris-HCl, pH 7.4. The gradients were 
centrifuged for 2.5 h at 25 000 rpm (90000 x g) in a Beckman 
SW 27 rotor. The turbid band at the 0.8 M/l .2 M sucrose inter- 
face was harvested in a minimum volume by syringe puncture, 
diluted two-fold in 10 mM Tris-HCl, pH 7.4, and centrifuged at 
90000 x g for 1 h in the SW 27 rotor. The resulting pellet of 
Golgi membranes could be used immediately, or more conve- 
niently, frozen and stored at -80°C. The frozen membrane 
fractions should be thawed shortly before the assay by a short 
exposure to 37°C and maintained on ice prior to use. 
The following marker enzymes were used to confirm the puri- 
ty and the recovery of isolated Golgi-derived vesicles. They were 
enriched 143-fold in sialyltransferase specific activity (1.6% 
yield) [7], 0.96-fold in glucose-6-phosphatase pecific activity 
(0.01% yield) [8], 5-fold in 5’-nucleotide specific activity 
(0.06% yield) (81, 15fold in &hexosaminidase specific activity 
(0.175% yield) [8]. 
2.3. Preparation of radioactive and non-radioactive CMP- 
NeuSGc 
Unless stated otherwise, all procedures were carried out at 
4°C. 
2.3.1. Extraction of soluble protein from mouse liver 
Livers from freshly killed Balb/c mice were homogenized in 
5 vols (ml/g wt tissue) of ice-cold 50 mM Tris-HCl, pH 7.4, US- 
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ing a Potter-Elvehjem homogeniser and centrifuged at 
120000 x g (Beckman 45Ti rotor; 39000 rpm) for 1 h. The 
resulting supernatant was either used immediately or stored at 
- 70°C until use. 
2.3.2. Enzymatic hydroxylation of CMP-[‘4C]Neu5Ac by 
CMP-NeuSAc hydroxylase from mouse liver (EC 
1.14.99.18) 
37 kBq CMP-[i4C]Neu5Ac (purchased from New England 
Nuclear, D-6072 Dreieich; spec. act. 10.1 GBq/mmol) was in- 
cubated for 3 h at 37°C with 20 ml of the mouse liver superna- 
tant in the presence of 1 mM NADH and 0.5 mM 
FeS04.7HzO. The reaction was stopped by cooling on ice and 
protein was removed by ultrafiltration at 4°C (Sartorius mem- 
brane filter; 20000 Da molecular mass limit). The clear, col- 
ourless eluate from ultrafiltration was diluted two-fold with 
water and applied to a 1.4 x 26 cm column of Dowex 1 x 8 
(200-400 mesh; HCO: counterion) equilibrated in 10 mM tri- 
ethylamine hydrogencarbonate (pH 7.8). The column was wash- 
ed with 2 vols of equilibration buffer and developed with an 
800 ml linear gradient up to 1 M triethylamine hydrogencar- 
bonate (pH 7.8). Fractions containing CMP-[%]NeuSGc 
(emerging between 0.3 M and 0.4 M buffer) were pooled and 
lyophilised. The residue was resuspended in 1.5 ml of 0.3 M tri- 
ethylamine hydrogencarbonate (pH 7.8) and gel filtered on a 
1.5 x 80 cm column of Sephadex G-10 (superfine) equilibrated 
in 5 mM Tris-HCl (pH 7.4), collecting 1 ml fractions. Fractions 
constituting the main peak of radioactivity were pooled, 
lyophilised and resuspended in 1 ml water. 
The final product contained less than 1% CMP-[“C]NeuSAc 
as revealed by radio-TLC of the intact and acid-hydrolysed 
product [5]. Furthermore, no free sialic acid was detected by 
HPLC analyses using the conditions described by Gross et al. [9] 
and radiochemical detection. 
Non-radioactive CMP-NeuSGc was synthesised from CTP 
and NeuSGc using the CMP-sialate synthetase (EC 2.7.7.43) 
present in a soluble protein extract of frog liver [lo] and purified 
by the same ion-exchange and gel-filtration procedures de- 
scribed above. 
2.4. Protein determination 
Proteins from cells or Golgi vesicles, solubilized in the 
presence of SDS were estimated using a modification of the 
method of Lowry with bovine serum albumin as standard [1 11. 
2.5. Incubation of Goigi vesicles with CMP-[‘“C]sialic acid 
Golgi vesicles, which were found to be sealed and of the same 
membrane topography as in vivo (see section 3) were incubated 
in 0.25 M sucrose, 10 mM Tris-HCl (pH 7.4), 150 mM KCl, 
1 mM MgCl2, 5 mM MnClz and varying amounts of radio- 
labelled CMP-[i4C]sialic acid, in a total volume of 100 ~1. After 
incubation, the uptake of CMP-[‘4C]sialic acid by the Golgi 
vesicles and the transfer of [i4C]sialic acid onto endogenous ac- 
ceptors were determined by rapid filtration on millipore filters 
(GS type, 2.5 cm, pore size 0.22/cm), using a modified pro- 
cedure originally described by Fleischer [12]. 
The uptake of CMP-[i4C]sialic acid was determined by ad- 
ding 1 ml of ice-cold stop buffer (0.25 M sucrose; 10 mM Tris- 
HCl, pH 7.4; 1 mM MgClr) to one half of the incubation 
medium, followed by rapid filtration. The filter and retained 
vesicles were washed with 6 x 1 ml of the cold stop buffer. and 
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the radioactivity associated with the filter was then estimated by 
liquid scintillation counting. 
The transfer of [14C]sialic acid was determined by precipita- 
tion of the glycosylated acceptors present in the second half of 
the incubation medium with 5% phosphotungstic acid in 2 N 
HCl, followed by filtration through Millipore filters and further 
washing with 5% (w/v) trichloroacetic acid. The radioactivity 
associated with the filter was then counted. 
We have checked for non-specific adsorption of CMP-[‘4C]- 
sialic acid by addition of a lOO-fold excess of unlabelled CMP- 
sialic acid after incubation and prior to filtration on a Millipore 
filter. It was shown that there was no change in the amount of 
filter-associated CMP-[‘4C]sialic acid. 
3. RESULTS AND DISCUSSION 
3.1. Latency of sialyltransferase towards CMP- 
To be of physiological significance, the assay of 
CMP-[r4C]Neu5Gc uptake had to be performed 
only with Golgi vesicles shown to be sealed and of 
the same membrane topography as in vivo [13]. 
When sialyltransferases were assayed with increas- 
ing concentrations of Triton X-100 using labelled 
CMP-[r4C]Neu5Gc and unlabelled asialofetuin as 
the macromolecular exogenous acceptor [5], an in- 
creased incorporation was observed (fig.l), in- 
dicating that 91% of the Golgi vesicles were well 
sealed and of the same topographical orientation as 
in vivo. Furthermore, this approach provides 
evidence that CMP-[‘4C]Neu5Gc has to be capable 
of crossing intracellular membranes in order to be 
used by the sialyltransferases present in the lumen 
of the Golgi vesicles. 
3.2. Time course of CMP-[“CjNeuSGc 
penetration into mouse liver Golgi vesicles 
and of NeuSGc transfer onto endogenous 
acceptors 
Mouse liver Golgi vesicles were incubated with 
1.5 PM CMP-[14C]Neu5Gc. The rapid filtration 
technique resulted in virtually complete separation 
of the vesicles and incubation medium within 
seconds, in contrast to the alternative approach 
which involves a lengthy period of centrifugation 
[14]. Using this procedure, the rate of uptake of 
radiolabelled CMP-NeuSGc by Golgi vesicles was 
shown to be linear and rapid for the first 4 min, 
after which it decreased (fig.2). We also checked 
for [14C]Neu5Gc transfer onto endogenous accep- 
tors as a function of time (fig.2). Presumably, 
because of a high sialyltransferase activity and the 
low concentration of CMP-[14C]Neu5Gc used, 
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Fig. 1. Latency of sialyltransferase with endogenous acceptors 
and asialofetuin as exogenous acceptor. Golgi vesicles were in- 
cubated at 37°C for 4 min with CMP-(i4C]Neu5Gc (1 ,uM, 
63 000 dpm) in the presence or absence of asialofetuin (4 mg/ml) 
as exogenous acceptor, and various concentrations of Triton 
X-100 ranging from 0 to 0.3%. After incubation, the 
glycosylated acceptors were precipitated with phosphotungstic 
acid and washed by filtration with 5% trichloroacetic acid. The 
radioactivity associated with the filter was then counted. The in- 
corporation onto asialofetuin (O--O) was obtained by the dif- 
ference between two incubations one lacking exogenous accep- 
tor (H). 
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Fig.2. Time course of CMP-[r4C]Neu5Gc penetration into 
mouse liver Golgi vesicles and NeuSGc transfer onto en- 
dogenous acceptors. CMP-[r4C]NeuGc (1.5 FM, 94000 dpm) 
was incubated with Golgi vesicles in STM buffer (pH 7.4) at 
37°C for the times listed in the figures. (M) The total 
vesicle-associated radioactivity and the acid-precipitable 
radioactivity (H) (transport and transfer, respectively) were 
measured as described in section 2. 
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there was very little difference between total and 
acid-precipitable radioactivity. 
The transport of CMP-[14C]Neu5Gc was also 
dependent on temperature: uptake at 4°C being 
9% of that at 37°C (data not shown). 
The results obtained above on the temperature 
dependence and substrate concentration 
dependence of CMP-NeuSGc transport establish 
the existence of a carrier mechanism for CMP- 
NeuSGc in mouse liver Golgi vesicles. 
3.3. Concentration dependence of CMP-[‘4C]- 3.4. Specificity of CMP-NeuSGc transport 
NeuSGc transport 
The penetration rate of CMP-[i4C]Neu5Ac was 
saturable with increasing concentrations of CMP- 
[r4C]Neu5Ac (0.5-20 pM) in the medium (fig.3a). 
Initial uptake rates were measured with a 2 min in- 
cubation, and the resulting transfer of 
[14C]Neu5Ac onto endogenous acceptors studied. 
The points of the double reciprocal plot were fitted 
by linear regression analysis to a straight line 
(r = 0.998) which gave an apparent K, of 1.3 PM 
and a maximal velocity of 335 pmol/mg protein per 
min (fig.3a, inset). These values are of the same 
order of magnitude as those previously reported by 
Sommers and Hirschberg [14] for transport of 
CMP-NeuSAc into rat liver Golgi. 
Using exactly the same incubation conditions, 
we have shown (fig.3b) that the transport of CMP- 
NeuSGc is saturable with high concentrations of 
CMP-[‘4C]Neu5Gc in the medium, giving rise to an 
apparent K,,, of 1.25 /IM and a maximal velocity of 
325 pmol/mg protein per min (fig.3b, inset). 
To evaluate the specificity of this carrier process, 
radiolabelled CMP-[‘4C]Neu5Gc uptake by Golgi 
vesicles was assayed in the presence of various con- 
centrations of unlabelled CMP-NeuSAc up to 
lOO-fold greater (500 PM) than that of radiola- 
belled CMP-[‘4C]Neu5Gc (5pM). Uptake of CMP- 
[‘4C]Neu5Gc was inhibited by 50% at 8.5 PM 
CMP-NeuSAc as shown in fig.4b. The results of 
similar competitive studies performed using 
radiolabelled CMP-[‘4C]Neu5Ac and unlabelled 
CMP-NeuSGc under identical incubation condi- 
tions are shown in fig.4a. 50% inhibition was ob- 
tained at 5.6 pM CMP-NeuSGc. This behaviour is 
consistent with the existence of a single carrier 
molecule present in the mouse liver Golgi vesicles 
mediating the uptake of both CMP-NeuSAc and 
CMP-NeuSGc substrates. The presence of a N- 
acetyl group in the sugar moiety does not constitute 
an important recognition feature as it can be 
replaced by a N-glycoloyl group without any 
change in the uptake rate of the CMP-sialic acid. 
012 5 10 20 012 5 10 20 
CMP-[ 14C]NeuAc concentration (pM) CMP-[ 14C]NeuGc concentration (ptvl) 
Fig.3. Concentration dependence of CMP-NeuSGc transport. Golgi vesicles were incubated for 2 min with various concentrations of 
either CMP-[14C]Neu5Ac (a), or CMP-[‘4C]Neu5Gc (b). After incubation, the total vesicle-associated radioactivity (o-+, transport) 
and the acid-precipitable radioactivity (H, transfer) were measured as described in section 2. The insets show the Lineweaver-Burk 
plots. 
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Fig.4. Mutual competition between CMP-NeuSAc and CMP-NeuSGc for their uptake by mouse liver Golgi vesicles. Golgi vesicles were 
incubated 4 min at 37°C with either CMP-[‘4C]NeuSAc (5 PM, 277 500 dpm) and various concentrations of unlabelled CMP-NeuSGc 
ranging from 0 to 500 PM (a), or with CMP-[r4C]Neu5Gc (5 PM, 133 200 dpm) and various concentrations of CMP-NeuSAc ranging 
from 0 to 500 PM (b). Total vesicle-associated radioactivity (transport) was measured as described previously in section 2. 
3.5. Effect of intravesicular CMP 
Finally, as was hypothesized by Capasso and 
Hirschberg [3], we have checked for the existence 
of an antiport mechanism involving the exchange 
of CMP with CMP-NeuSGc. We set out to deter- 
mine whether the uptake of CMP-NeuSGc from 
16 
0 2 5 15 
incubation time (min) 
Fig.5. Effect of preloading Golgi vesicles with CMP on the up- 
take of CMP-[“‘C]NeuSGc. Golgi vesicles were preincubated 
for 10 min at 37°C with lOOaM CMP (O--O) or without CMP 
(-). The extravesicular CMP was removed by centrifuga- 
tion and further washing with the STM buffer and the Golgi 
vesicles were incubated for various times shown in the figure 
with 2 PM CMP-[%]NeuSGc at 37°C. The total vesicle- 
associated radioactivity was measured as described in section 2. 
the cytoplasm was coupled with an exchange of 
CMP from the lumen by preloading Golgi vesicles 
with 100 ,uM CMP for 10 min. Previous ex- 
periments showed that Golgi vesicles were able to 
take up CMP (data not shown) as already described 
by Fleischer 112,151. After removing extravesicular 
CMP by repeated centrifugation and washing, the 
CMP-preloaded vesicles were then incubated with 
2 ,uM CMP-[“4C]Neu5Gc and its uptake 
measured. 
The results in fig.5 show that under these condi- 
tions, the total radioactivity associated with the 
vesicles, corresponding to CMP-NeuSGc uptake, 
was enhanced with time in CMP-preloaded ve- 
sicles. This stimulating effect of increased lumenal 
CMP concentrations suggests an exchange 
mechanism between intravesiclar CMP and ex- 
travesicular CMP-NeuSGc. 
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